tiprankstipranks
Trending News
More News >
Enliven Therapeutics (ELVN)
NASDAQ:ELVN
US Market
Advertisement

Enliven Therapeutics (ELVN) Technical Analysis

Compare
303 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Enliven Therapeutics’s (ELVN) Moving Averages Convergence Divergence (MACD) indicator is 0.29, suggesting Enliven Therapeutics is a Buy.
Enliven Therapeutics’s (ELVN) 20-Day exponential moving average is 20.67, while Enliven Therapeutics’s (ELVN) share price is $20.61, making it a Sell.
Enliven Therapeutics’s (ELVN) 50-Day exponential moving average is 20.33, while Enliven Therapeutics’s (ELVN) share price is $20.61, making it a Buy.

Enliven Therapeutics (ELVN) Pivot Points

Oct 26, 2025, 05:32 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.27
19.77
20.16
20.65
21.04
21.54
21.93
Fibonacci
19.77
20.10
20.31
20.65
20.99
21.20
21.54
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Enliven Therapeutics (ELVN) Moving Averages

Oct 26, 2025, 05:32 AM
Period
Simple
Exponential
MA5
20.99Sell
20.82Sell
MA10
21.06Sell
20.88Sell
MA20
20.68Sell
20.67Sell
MA50
20.16Buy
20.33Buy
MA100
20.44Buy
20.29Buy
MA200
20.16Buy
20.91Sell
Enliven Therapeutics’s (ELVN) 10-Day exponential moving average is 20.88, while Enliven Therapeutics’s (ELVN) share price is $20.61, making it a Sell.
Enliven Therapeutics’s (ELVN) 100-Day exponential moving average is 20.29, while Enliven Therapeutics’s (ELVN) share price is $20.61, making it a Buy.
Enliven Therapeutics’s (ELVN) stock price is $20.61 and Enliven Therapeutics’s (ELVN) 50-day simple moving average is 20.16, creating a Buy signal.
Enliven Therapeutics’s (ELVN) stock price is $20.61 and Enliven Therapeutics’s (ELVN) 100-day simple moving average is 20.44, creating a Buy signal.
Enliven Therapeutics’s (ELVN) stock price is $20.61 and Enliven Therapeutics’s (ELVN) 200-day simple moving average is 20.16, creating a Buy signal.

Enliven Therapeutics (ELVN) Technical Indicators

Oct 26, 2025, 05:32 AM
Name
Value
Implied Action
RSI (14)
50.52
Neutral
STOCH (9,6)
23.53
Neutral
STOCHRSI (14)
35.32
Neutral
MACD (12,26)
0.29
Buy
ADX (14)
17.89
Buy
Williams %R
-74.02
Buy
CCI (14)
-13.10
Neutral
ATR (14)
1.02
-
Ultimate Oscillator
43.93
Neutral
ROC
1.53
Buy
Enliven Therapeutics’s (ELVN) Relative Strength Index (RSI) is 50.52, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Trend Strength Indicator (ADX) is 17.89, creating a Buy signal.
Enliven Therapeutics’s (ELVN) Commodity Channel Index (CCI) is -13.10, creating a Neutral signal.
Enliven Therapeutics’s (ELVN) Price Rate of Change (ROC) is 1.53, creating a Buy signal.

FAQ

Is ELVN a Buy, Hold, or Sell?
Based on ELVN’s technical indicators, ELVN is a Hold.
    What is ELVN’s RSI (14)?
    ELVN’s RSI (14) is 50.52, which suggests ELVN is a Neutral.
      What is ELVN’s MACD?
      ELVN’s MACD is 0.29, which suggests ELVN is a Buy.
        What is ELVN’s 5-day moving average?
        ELVN’s 5-day moving average is 20.99, which suggests ELVN is a Sell.
          What is ELVN’s 20-day moving average?
          ELVN 20-day moving average is 20.68, which suggests ELVN is a Sell.
            What is ELVN’s 50-day moving average?
            ELVN’s 50-day moving average is 20.16, which suggests ELVN is a Buy.
              What is ELVN’s 200-day moving average?
              ELVN’s 200-day moving average is 20.16, which suggests ELVN is a Buy.
                What is ELVN’s Williams % R (14)?
                ELVN’s Williams % R (14) is -74.02, which suggests ELVN is a Buy.
                  What is ELVN’s CCI (14)?
                  ELVN’s CCI (14) is -13.10, which suggests ELVN is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis